Heron Therapeutics, Inc. (HRTX)
Nasdaq: HRTX · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 1994
Who owns Heron Therapeutics, Inc.
As filed with the SECHolders of 5% or more
2
Rubric Capital Management LP holds 15.9% of Common Stock, par value $0.01 per share, as its SCHEDULE 13D/A filed Oct 17, 2025 says.
Directors and officers
10
report now, of 25 people on the record since 2007. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Rubric Capital Management LP
SCHEDULE 13D/A · filed Oct 17, 2025 · Common Stock, par value $0.01 per share · 17.5% in Aug 12, 2025
Clearline Capital LP
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.01 per share · 5.3% in Nov 26, 2025
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed May 13, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.35% in Jan 30, 2026
What HRTX reports owning in othersstakes of 5% or more, and other ties
Heron Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 10, 2025 to Nov 10, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Nov 10, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.